Haiyuan Zhu
About Haiyuan Zhu
Haiyuan Zhu is the VP, Head of Biometrics at Karuna, a Bristol Myers Squibb company, with over 22 years of experience in the pharmaceutical industry.
Current Role at Bristol Myers Squibb
Haiyuan Zhu currently serves as the Vice President, Head of Biometrics at Karuna, a Bristol Myers Squibb company. In this role, Haiyuan Zhu oversees the biometrics division, including biostatistics, statistical programming, and data management. His leadership is vital to the strategic direction and success of the department.
Previous Position at Karuna Therapeutics
From 2021 to 2024, Haiyuan Zhu worked as the Vice President, Head of Biometrics at Karuna Therapeutics in Boston, Massachusetts. During this period, he was responsible for biostatistics, statistical programming, and data management. His role was crucial in developing and implementing data-driven strategies.
Employed at Sunovion Pharmaceuticals
Between 2018 and 2021, Haiyuan Zhu served as Senior Director, Biostatistics at Sunovion Pharmaceuticals in Fort Lee, New Jersey. His responsibilities included overseeing biostatistical projects and contributing to the company's key data initiatives.
Role at Allergan
Haiyuan Zhu held various positions at Allergan, including Executive Director, Director, and Associate Director, from 2010 to 2018. Based in Jersey City and Madison, New Jersey, he played a significant role in advancing the company’s statistical and data management capabilities.
Early Career at Merck
Haiyuan Zhu began his career at Merck, serving as a Biometrician from 2002 to 2006 and later as Senior Biometrician from 2006 to 2010. During his tenure, he was involved in critical biometric analyses and contributed to multiple research projects.
Academic Background
Haiyuan Zhu earned a Ph.D. in Statistics and an M.S. in Computer Science from the University of Illinois Chicago between 1997 and 2002. Prior to this, he received an M.S. and B.S. in Mathematics from Beijing Normal University. His solid academic foundation has significantly contributed to his expertise in biostatistics and data management.
New Drug Applications and Data Monitoring
With over 22 years in the pharmaceutical industry, Haiyuan Zhu has successfully led the submission and support of multiple New Drug Applications (NDAs). He has also played a key role in establishing central data monitoring systems and statistical computing environments at various organizations.